Literature DB >> 15718361

Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits.

Kajsa Bohlin1, Rabea K L Bouhafs, Connie Jarstrand, Tore Curstedt, Mats Blennow, Bengt Robertson.   

Abstract

In preterm infants with respiratory distress syndrome, surfactant administration followed by immediate extubation to spontaneous breathing with nasal continuous positive airway pressure reduces the need for mechanical ventilation. With this treatment approach, repeated doses of surfactant are rarely indicated. We used a rabbit model to test the hypothesis that exogenous surfactant therapy followed by spontaneous breathing results in a more sustained initial treatment response compared with treatment followed by mechanical ventilation. Preterm rabbits (gestational age 28.5 d) were treated with pharyngeal deposition of 200 mg/kg radiolabeled surfactant (14C-Curosurf) and randomized to 4 h of spontaneous breathing or mechanical ventilation or to a control group, killed immediately after surfactant administration. With pharyngeal deposition, 46 +/- 10% (mean +/- SEM) of the administered surfactant reached the lungs. The dynamic lung-thorax compliance was higher in spontaneously breathing compared with mechanically ventilated animals (median, 9.9 and 0.75 ml x cm H2O(-1) x kg(-1), respectively; p < 0.05). The relative distribution of 14C-Curosurf in bronchoalveolar lavage fluid and homogenized lung tissue showed a higher degree of tissue association in the spontaneously breathing animals [53 +/- 4 versus 26 +/- 3% (mean +/- SEM)] than in mechanically ventilated animals (p < 0.01), the latter figure being very similar to that of the control group (25 +/- 5%). There was a higher degree of lipid peroxidation and fewer microbubbles in bronchoalveolar lavage fluid from mechanically ventilated animals. We conclude that the initial lung tissue association of exogenous surfactant is impaired by mechanical ventilation. This is associated with a reduction of dynamic compliance and evidence of increased surfactant inactivation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718361     DOI: 10.1203/01.PDR.0000156502.84909.BC

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

1.  Outcome of intubate surfactant rapidly extubate (InSuRE): an Indian experience.

Authors:  Amit Tagare; Sandeep Kadam; Umesh Vaidya; Anand Pandit
Journal:  Indian J Pediatr       Date:  2013-06-18       Impact factor: 1.967

Review 2.  Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.

Authors:  H J Niemarkt; M C Hütten; Boris W Kramer
Journal:  Neonatology       Date:  2017-05-25       Impact factor: 4.035

Review 3.  Surfactant therapy: the current practice and the future trends.

Authors:  Khalid Altirkawi
Journal:  Sudan J Paediatr       Date:  2013

Review 4.  Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.

Authors:  Vincent Rigo; Caroline Lefebvre; Isabelle Broux
Journal:  Eur J Pediatr       Date:  2016-09-27       Impact factor: 3.183

5.  Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.

Authors:  J M B Pinheiro; Q Santana-Rivas; C Pezzano
Journal:  J Perinatol       Date:  2015-12-03       Impact factor: 2.521

6.  Non-destructive vacuum-assisted measurement of lung elastic modulus.

Authors:  Jiawen Chen; Seyed Mohammad Mir; Meghan R Pinezich; John D O'Neill; Brandon A Guenthart; Matthew Bacchetta; Gordana Vunjak-Novakovic; Sarah X L Huang; Jinho Kim
Journal:  Acta Biomater       Date:  2021-06-27       Impact factor: 10.633

7.  Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats.

Authors:  Yu Sun; Rui Yang; Ji-gen Zhong; Feng Fang; Jin-jin Jiang; Ming-yao Liu; Jian Lu
Journal:  Crit Care       Date:  2009-03-04       Impact factor: 9.097

8.  Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant.

Authors:  Hanna Müller; Caroline End; Marcus Renner; Burkhard M Helmke; Nikolaus Gassler; Christel Weiss; Dominik Hartl; Matthias Griese; Mathias Hafner; Annemarie Poustka; Jan Mollenhauer; Johannes Poeschl
Journal:  Respir Res       Date:  2007-10-01

9.  The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.

Authors:  Peter A Dargaville; Camille Omar F Kamlin; Antonio G De Paoli; John B Carlin; Francesca Orsini; Roger F Soll; Peter G Davis
Journal:  BMC Pediatr       Date:  2014-08-27       Impact factor: 2.125

10.  Less invasive beractant administration in preterm infants: a pilot study.

Authors:  Cristina Ramos-Navarro; Manuel Sánchez-Luna; Susana Zeballos-Sarrato; Noelia González-Pacheco
Journal:  Clinics (Sao Paulo)       Date:  2016-03       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.